BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu SR, Yan Q, Lin HM, Shi GZ, Cao Y, Zeng H, Liu C, Zhang R. Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reports. World J Clin Cases 2021; 9(21): 5988-5998 [PMID: 34368318 DOI: 10.12998/wjcc.v9.i21.5988]
URL: https://www.wjgnet.com/2307-8960/full/v9/i21/5988.htm
Number Citing Articles
1
Roma Raj, Chase J. Wehrle, Nihal Aykun, Henry Stitzel, Wen Wee Ma, Smitha Krishnamurthi, Bassam Estfan, Suneel Kamath, David C. H. Kwon, Federico Aucejo. Immunotherapy Plus Locoregional Therapy Leading to Curative-Intent Hepatectomy in HCC: Proof of Concept Producing Durable Survival Benefits Detectable with Liquid BiopsyCancers 2023; 15(21): 5220 doi: 10.3390/cancers15215220
2
Qin-qin Liu, Hao-ming Lin, Hong-wei Han, Cai-ni Yang, Chao Liu, Rui Zhang. Complete Response to Combined Chemotherapy and Anti-PD-1 Therapy for Recurrent Gallbladder Carcinosarcoma: A Case Report and Literature ReviewFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.803454